Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
In Vitro Fertilization
100%
Indonesia
89%
Anti-Müllerian Hormone
70%
Jakarta
54%
Endometriosis
53%
Polycystic Ovary Syndrome
51%
Infertility
46%
Indonesian
45%
Granulosa Cells
42%
Women of Reproductive Age
39%
Anti-mullerian Hormone Levels
36%
Polycystic Ovarian Syndrome
36%
Fertility Preservation
34%
Oocyte Quality
29%
Ovarian Reserve
26%
Hormone Levels
25%
Biological Age
24%
Aneuploidy
23%
COVID-19
23%
Body Mass Index
21%
Oocyte Maturation
21%
Smartphone
20%
Vitrification
20%
Poor Responders
19%
Gene Expression
19%
Growth Differentiation Factor 9 (GDF9)
19%
Smart Applications
18%
Peer Review
18%
Embryo Quality
17%
Controlled Ovarian Stimulation
16%
Success Rate
16%
Follicle-stimulating Hormone
16%
Healthcare Providers
16%
MRNA Expression
16%
Endometriosis Patients
15%
Embryo Image
15%
Reproductive Health
15%
Assisted Reproductive Technology
14%
Luteinizing Hormone
14%
B-cell Lymphoma 2 (Bcl-2)
14%
In Vitro Fertilization Cycle
14%
Recombinant Human Follicle-stimulating Hormone (r-hFSH)
14%
MicroRNA
14%
Statistical Analysis
13%
Endometrium
13%
Insulin Resistance
13%
Follicular Fluid
13%
Infertility Care
13%
Human Granulosa Cells
13%
Hormone Receptor Expression
13%
Medicine and Dentistry
In Vitro Fertilisation
95%
Oocyte
70%
Polycystic Ovary Syndrome
63%
Muellerian Inhibiting Factor
58%
Endometriosis
49%
Hormone Determination
47%
Fertility Preservation
43%
Granulosa Cell
40%
Cross Sectional Study
37%
Follitropin
34%
Assisted Reproductive Technology
33%
Reproductive Age
33%
Reproductive Medicine
32%
Polycystic Ovarian Syndrome
31%
fertility
30%
Body Mass Index
28%
Malignant Neoplasm
24%
Aneuploidy
24%
Blastocyst
22%
Reproductive Public Health
20%
Vitrification
20%
Gene Expression
19%
Embryo Culture
18%
Ovarian Reserve
18%
Messenger RNA
17%
Pregnancy Rate
16%
Controlled Ovarian Hyperstimulation
16%
Receptivity
15%
Drospirenone Plus Ethinylestradiol
15%
Hyperandrogenism
14%
Androgen
14%
Antral Follicle
14%
microRNA
14%
Luteinizing Hormone
13%
Systematic Review
13%
Mobile Health
13%
Cell-Free DNA
13%
Follicle
12%
Education
12%
Genetic Screening
11%
Health Service
11%
Homeostatic Model Assessment
11%
Oocyte Maturation
11%
Area under the Curve
10%
Semen Analysis
10%
In Vitro
10%
Morphology
10%
Adolescence
10%
Biological Marker
9%
COVID-19
9%